Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
0.295
-0.019 (-6.05%)
At close: Feb 21, 2025, 4:00 PM
0.300
+0.005 (1.69%)
After-hours: Feb 21, 2025, 7:13 PM EST
Relmada Therapeutics Market Cap
Relmada Therapeutics has a market cap or net worth of $8.90 million as of February 21, 2025. Its market cap has decreased by -94.52% in one year.
Market Cap
8.90M
Enterprise Value
-45.22M
1-Year Change
-94.52%
Ranking
Category
Stock Price
$0.30
Market Cap Chart
Since September 30, 2015, Relmada Therapeutics's market cap has decreased from $56.60M to $8.90M, a decrease of -84.27%. That is a compound annual growth rate of -17.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 8.90M | -43.31% |
| Dec 31, 2024 | 15.70M | -87.40% |
| Dec 29, 2023 | 124.60M | 18.67% |
| Dec 30, 2022 | 105.00M | -73.42% |
| Dec 31, 2021 | 395.00M | -24.17% |
| Dec 31, 2020 | 520.90M | 30.00% |
| Dec 31, 2019 | 400.70M | 1,125.38% |
| Dec 31, 2018 | 32.70M | 247.87% |
| Dec 29, 2017 | 9.40M | -28.24% |
| Dec 30, 2016 | 13.10M | -54.67% |
| Dec 31, 2015 | 28.90M | -48.94% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |